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Reactive oxygen species (ROS) contribute to target-
cell damage in inflammatory and iron-overload
diseases. Little is known about iron transport regula-
tion during inflammatory attack. Through a combina-
tion of in vitro and in vivo studies, we show that the
proinflammatory cytokine IL-1b induces divalent
metal transporter 1 (DMT1) expression correlating
with increased b cell iron content and ROS produc-
tion. Iron chelation and siRNA and genetic knock-
down of DMT1 expression reduce cytokine-induced
ROS formation and cell death. Glucose-stimulated
insulin secretion in the absence of cytokines in
Dmt1knockout islets isdefective,highlightingaphys-
iological role of iron and ROS in the regulation of
insulin secretion. Dmt1 knockout mice are protected
against multiple low-dose streptozotocin and high-
fat diet-induced glucose intolerance, models of
type 1 and type 2 diabetes, respectively. Thus, b cells
become prone to ROS-mediated inflammatory
damage via aberrant cellular iron metabolism, a
finding with potential general cellular implications.
INTRODUCTION
Inflammation and oxidative stress contribute to the pathophysi-
ology of the grand global health challenges: diabetes, cancer,Cellneurodegenerative disorders, hypertension, and cardiovascular
diseases. Inflammatory generation of reactive oxygen species
(ROS) depends on the Fenton reaction catalyzed by redox-active
metals, of which iron predominates. Iron overload causes oxida-
tive stress and subsequent mitochondrial and DNA damage,
lipid peroxidation, and protein modification, leading in particular
to dysfunction of metabolically highly active cells, e.g., cardio-
myocytes, hepatocytes, pituitary cells, chondrocytes, and
pancreatic b cells (Eaton and Qian, 2002; Hamazaki et al.,
1986; Jomova and Valko, 2011; Witzleben, 1966).
Proinflammatory cytokines generated by islet-infiltrating
immune cells in type 1 and 2 diabetes are believed to impair
b cell function and viability, in part via ROS formation, to which
b cells are exquisitely sensitive due to inadequate antioxidative
defense (Donath et al., 2008; Lenzen et al., 1996; Lenzen, 2008).
Pancreatic and duodenal homeobox 1 (Pdx-1) is a central tran-
scription factor regulating pancreatic development and islet
b cell function and maintaining b cell-specific gene expression
(Kaneto et al., 2007). Constitutively overexpressed Pdx-1 also
sensitizes b cells to cytokine-induced apoptosis (Ammendrup
et al., 2000; Nielsen et al., 1999, 2004). However, the molecular
mechanisms of Pdx-1-enhanced cytokine sensitivity need to
be defined, since they represent potential therapeutic targets.
Cytokine exposure and subsequent NFkB activity are impli-
cated in the metabolic syndrome leading to insulin resistance
via both central and peripheral pathways (Arkan et al., 2005;
Yuan et al., 2001; Cai et al., 2005; Zhang et al., 2008). Likewise,
cytokine-mediated b cell apoptosis depends on persistent acti-
vation of the MAP kinase and NFkB signaling pathways (Aikin
et al., 2004; Eldor et al., 2006; Giannoukakis et al., 2000;Metabolism 16, 449–461, October 3, 2012 ª2012 Elsevier Inc. 449
Figure 1. Pdx-1 Overexpression Sensitizes b Cells to IL-1b-Induced
Apoptosis and Induces Changes in Iron- and ROS-Related Gene
Expression
(A) Replicate western blot analyses of cleaved caspase-3 after 24 hr of IL-1b
exposure in INS-1rab cells with doxycycline (dox)-induced overexpression of
Pdx-1.
(B) Apoptosis measured by cytosolic histone-DNA complexes in Pdx-1-
overexpressing cells exposed to IL-1b for 24 hr. Graphs show means + SEM,
n = 3–5, *p < 0.05, Student’s t test.
(C) Left: Heat map showing log2-transformed fold changes of genes in INS-
1rab cells with or without Pdx-1 overexpression upon 2 and 24 hr exposure to
150 pg/ml IL-1b (IL1b). Rows represent the 693 individual probe sets. Middle:
Log2-transformed gene changes after IL-1b exposure in INS-1rab cells with or
without Pdx-1 overexpression upon 2 and 24 hr exposure to IL-1b. Right:
Positions (black bars) of genes involved in ROS and iron related biological
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nisms involve endoplasmic reticulum stress, mitochondrial
dysfunction, and ROS generation (Donath et al., 2008). ROS
potentiates NFkB transcriptional activity, thereby establishing
a vicious cycle of progressive cellular imbalance between pro-
and antioxidant factors, leading to oxidative stress and cell
damage (Lenzen et al., 1996; Lenzen, 2008; Tiedge et al., 1997).
Here, we hypothesized that b cells may be primed to inflam-
matory damage not only because of inadequate antioxidative
defense but also due to aberrantly increased ROS production
associated with cytokine-induced Pdx-1-dependent upregula-
tion of proteins controlling cellular iron import.
RESULTS
Pdx-1 Overexpression Sensitizes to IL-1b-Induced
Apoptosis
Pdx-1-overexpressing cells (Wang et al., 2001; Wang et al.,
2005) (Figures S1A and S1B available online) were more sensi-
tive to the proapoptotic action of IL-1b, as demonstrated by
cleavage of caspase-3 and cytoplasmic histone-DNA
complexes, when compared to cells not exposed to dox- or
dn-Pdx-1-overexpressing cells (Figures 1A, 1B, S1C, and
S1D). IL-1b or IL-1b plus IFN-g-induced cleaved caspase-3
was also significantly enhanced in insulin-positive compared to
insulin-negative primary rat acinar and human fetal liver cells
transdifferentiating into b cell phenotypes (Baeyens et al.,
2005; Zalzman et al., 2003; Zalzman et al., 2005) (Figures S1E
and S1F).
To elucidate mechanisms of action underlying Pdx-1-driven
potentiation of b cell sensitivity to IL-1b, we performed amicroar-
ray analysis of INS-1ab cells with and without Pdx-1 overexpres-
sion exposed to 150 pg/ml IL-1b for 2 and 24 hr. A three-step bio-
informatic procedure was applied to identify differentially
expressed genes in response to IL-1b, depending on the pres-
ence or absence of Pdx-1 overexpression. First, we confirmed
time-dependent regulation of numerous gene clusters by IL-1b
by recording the differences between control INS-1rab versus
IL-1b exposed INS-1rab cells not overexpressing Pdx-1 (Fig-
ure 1C, left). Second, gene expression in INS-1rab cells overex-
pressing Pdx-1 in the presence or absence of IL-1b differed with
regard to 693 probe sets (Figure 1C, middle). Third, among the
Pdx-1-dependent IL-1b-responding genes identified in this
manner, enrichment analysis highlighted significant overrepre-
sentation of genes implicated in oxygen homeostasis and
response to oxidative stress (Figure 1C, right, lane 1, p =
0.006) and metal ion homeostasis and response to metal ions
(Figure 1C, right, lane 2, p = 0.001), respectively.
Nineteen transcription factors (TFs) significantly regulating
Pdx-1-dependent differential gene expression in IL-1b-exposed
INS-1rab cells were identified (Figure 2A). Using the STRING
database (Szklarczyk et al., 2011), 16 of these 19 TFs demon-
strated high-confidence interactions, with NFkB as a centralprocesses. Genes marked in bold are involved in both processes of which
three were NFkB targets (arrows). Slc11a2 appeared twice in the microarray,
representing DMT1 with the +IRE and DMT1 with both the +IRE and –IRE
isoforms. p values were calculated by hypergeometric testing.
See also Figure S1.
c.
Figure 2. IL-1b-Induced NFkB Signaling Is
Increased in Pdx-1-Overexpressing Cells
(A) Heat map showing Z scores for transcription
factor genes with significantly induced (red) or
repressed (green) expression upon exposure to
150 pg/ml IL-1b for 2 and 24 hr.
(B) Network of the 16 transcription factors with
high-confidence associations.
(C) Nuclear extracts from Pdx-1-overexpressing
INS-1rab cells exposed to IL-1b (150 pg/ml) for
1 hr. Nuclear extracts were subjected to electro-
phoretic mobility shift assay (EMSA) with a radio-
actively labeled NFkB-binding oligonucleotide as
probe. Lane 1, control cells; lane 2, Pdx-1-over-
expressing cells; lane 3, IL-1b-exposed cells; lane
4, Pdx-1-overexpressing and IL-1b-exposed cells;
lane 5, competition (Com) with excess (3100) cold
probe; lane 6, supershift with p65 antibody (Ab);
lane 7, free probe. The EMSA is representative of
n = 2.
(D) Cells were transiently transfected with an
NFkB Firefly Luciferase construct in addition to
a Renilla Luciferase construct as internal control.
Cells were then treated with doxycycline (dox)
for 24 hr followed by 6 hr exposure to 150 pg/ml
IL-1b. Means + SEM, n = 6, *p < 0.05, Student’s
t test.
(E) IL-1b-induced reactive oxygen species (ROS)
production in INS-1rab ± Pdx-1 overexpression
was measured with a fluorescent, cell-perme-
able indicator for reactive oxygen species (CM-
H2DCFDA). Means + SEM of n = 3, *p < 0.05,
Student’s t test.
See also Figure S2.
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(Figure 2B). When linking the Pdx-1-dependent differentially
regulated genes in Figure 1C with the TF analysis in Figures 2A
and 2B, NFkB target genes associated with oxygen homeostasis
and response to oxidative stress, as well as with iron homeo-
stasis and response to metal ions, were overrepresented (genes
in bold, Figure 1C). Three NFkB targets, Slc11a2 (solute carrier
family 11, member 2 also named iron transporting divalent metal
transporter 1 [Dmt1]), lipocalin 2 (Lcn2), and prostaglandinendo-
peroxide synthase/cyclooxygenase (Ptgs2), were significantly
overrepresented in both the oxygen homeostasis and
response to oxidative stress, as well as the iron homeostasis
and response to metal ions pathways (p = 0.005). We therefore
progressed with experimental validation of the roles of NFkB,
DMT1, iron transport, and ROS in sensitizing b cells to inflamma-
tory damage.Cell Metabolism 16, 449–461Pdx-1 Expression Facilitates IL-1b
Induced NFkB Activity and ROS
Formation
IL-1b exposure causes a rapid and sus-
tained proapoptotic activation of NFkB
and MAPK in b cells (Ammendrup et al.,
2000; Eldor et al., 2006; Giannoukakis
et al., 2000; Heimberg et al., 2001; Larsen
et al., 1998; Ortis et al., 2006). Since the
transcription factor network in Figure 2Bindicated a central role for NFkB activity in Pdx-1 sensitization
of b cells to IL-1b toxicity, we investigated the effect of Pdx-1
overexpression on IL-1b-induced NFkB activation. IL-1b-
induced NFkB activity was increased in Pdx-1-overexpressing
cells compared to wild-type and dn-Pdx-1-overexpressing cells,
measured by increased IkBa degradation, binding of p65 to
oligonucleotide kB binding sites, and NFkB transcriptional
activity (Figures 2C, 2D, S2A, S2C, and S2D). Accordingly, we
found increased expression of several NFkB target genes in
Pdx-1-overexpressing cells compared to wild-type cells
(Figure S2B).
The microarray analysis highlighting regulation of genes impli-
cated in oxygen homeostasis and responses to oxidative stress
was validated by the finding that IL-1b-induced ROS formation
was significantly enhanced in the INS-1rab cells overexpressing
Pdx-1 (Figure 2E)., October 3, 2012 ª2012 Elsevier Inc. 451
Figure 3. IL-1b Exposure Increases Expression of the Iron Transporter DMT1 in b Cells
(A) Quantification of mRNA from the microarray in Figure 1C showing 150 pg/ml IL-1b-induced DMT1 expression in INS-1rab with or without Pdx-1 over-
expression induced by doxycycline (dox). Means + SEM of four individual experiments, ***p < 0.001, two-way ANOVA.
(B) Western blot analysis for DMT1 in lysates of rat islets (left) exposed to 150 pg/ml IL-1b + 5 ng/ml IFN-g (Mix) for 24 hr. Blot is representative of n = 5.
Quantification of DMT1 protein expression in islets from two human donors (right) exposed to 160 pg/ml IL-1b + 5 ng/ml IFN-g (Mix) for 10 hr. Graphs show
means + SEM.
(C) DMT1 gene expression determined by real-time qPCR of IL-1b-exposed INS-1 cells (left) or rat islets (right) precultured with a cell-permeable IKKb inhibitor
(1 mM). The graph shows means + SEM, n = 3, *p < 0.05, Student’s t test.
(D) Effect of a 24 hr IL-1b exposure of isolated rat islets on the intracellular labile iron pool (LIP), measured as quenching of calcein fluorescence. Means + SEM,
n = 4, paired Student’s t test, ***p < 0,005.
See also Figure S3.
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DMT1
Having demonstrated that Pdx-1 facilitates IL-1b signaling we
focused on the expressional regulation of the NFkB-regulated
iron transporter DMT-1 (Ingrassia et al., 2012; Paradkar and
Roth, 2006a). IL-1b-induced DMT1 messenger RNA (mRNA)
expression as found by microarray comparison of INS-1rab cells
with and without Pdx-1 overexpression was verified by western
blotting showing increased DMT1 protein expression in cyto-
kine-exposed rat islets and islets from two human donors
(Figures 3A and 3B).
The gene cluster analysis in Figure 2B pointed to NFkB as
central signaling node in the network, and the DMT1 promoter
contains NFkB binding sites (Paradkar and Roth, 2006a,
2006b). We therefore pre-exposed INS-1 cells and isolated rat
islets to a cell-permeable IKKb inhibitor that blocks NFkB activa-
tion (Figure S3A) (Friberg et al., 2010). IKKb inhibition almost
completely prevented IL-1b-induced Dmt1 mRNA expression,
demonstrating pronounced dependence of IL-1b-induced
Dmt1 expression on NFkB activity (Figure 3C).452 Cell Metabolism 16, 449–461, October 3, 2012 ª2012 Elsevier InIL-1b Increases Islet Labile Iron Pool
Using confocal microscopy, we localized DMT1 to islet cell
cytosol, with a staining pattern compatible with endosomal
compartmentalization (Figure S3B). Since DMT1 is a transmem-
brane iron transporter involved in endosomal-to-cytoplasmic
iron transport (Mims and Prchal, 2005), we next showed that
IL-1b-induced increase in DMT1 expression correlated with
increased intracellular labile iron pool (LIP) in rat islets (Figure 3D).
This correlated with increased expression of Lcn2 and transferrin
receptor (TrfR), known mediators of iron import, and decreased
expression of the iron exporter ferroportin (Figure S3C). Thus,
inflammatory conditions promote reprogramming of the b cell
to favor iron accumulation.
Iron Chelation and DMT-1 siRNAs Protect against
Cytokine-Induced b Cell Apoptosis
IL-1b-induced ROS formation and apoptosis were inhibited by
the iron chelators desferrioxamine (DFO) and deferasirox
(D-Sirox) in primary rat islets and in INS-1E cells, effects that
were reversed by subsequent medium replenishment of ironc.
Figure 4. Iron Chelation and DMT1 Knockdown Protect against IL-1b-Induced ROS Formation and Apoptosis
(A) Inhibition of 150 pg/ml IL-1b-inducedROS formation in rat islets pretreated for 24 or 1 hr, respectively, with the iron chelators desferrioxamine (DFO) (0.1mM) or
deferasiox (D-Sirox) (0.025mM). ROSwasmeasuredwith the fluorescent, cell-permeable indicatorCM-H2DCFDA.Means+SEM, n= 6, Student’s t test, *p <0.05.
(B) IL-1b-induced cell death measured as cytosolic DNA-histone complexes after 24 hr in rat islets pretreated with DFO or D-Sirox. Means + SEM, n = 3–4,
*p < 0.05, Student’s t test.
(C) INS-1 cells were left nontransfected (ntx), or transfected with 30 nM of control (Dharmafect), scrambled siRNA, or three different siRNA targeting DMT1. After
2 days of recovery, cells were left untreated or exposed to 150 pg/ml IL-1b for 24 hr.Western blotting of cell lysates with DMT1 and cleaved caspase-3 (cl. casp3)-
and b-actin-specific antibodies was performed (left). Mean optical density measurements of cleaved caspase-3 were corrected for protein loading by b-actin in
IL-1b-exposed cells (right). n = 6, means + SEM, *p < 0.05, Student’s t test.
See also Figure S4.
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with three different DMT1-targeted small interfering RNAs
(siRNAs) resulted in a reduction of IL-1b-induced DMT1 expres-
sion and cleaved caspase-3 in INS-1E cells (Figure 4C).
b Cell-Specific Dmt1 Knockout Protects from Cytokine-
Induced Apoptosis
We generated an inducible b cell-specific Dmt1 knockout (KO)
mouse by crossing a floxed Dmt1 mouse (Gunshin et al., 2005),Cellwith a mouse carrying the cre recombinase (cre) gene fused to
the mutated estrogen receptor driven by the Pdx-1 promoter
(Gu et al., 2002), resulting in specific excision of exons 6–8 of
the Dmt1 gene in Pdx-1-expressing cells upon tamoxifen treat-
ment (Figure 5A). In animals carrying the cre gene, cre translo-
cation was observed in most insulin-positive cells 12 hr after
tamoxifen treatment (Figure 5B). A Dmt1 knockdown efficiency
of approximately 80% as quantified by RT-PCR of mRNA
from isolated islets was anticipated since islets containMetabolism 16, 449–461, October 3, 2012 ª2012 Elsevier Inc. 453
Figure 5. DMT1 Deletion Protects b Cells from Cytokine-Induced Apoptosis
(A) Tamoxifen (TAM)-inducible cre-lox recombination was used to generate b cell-specific DMT1 knockout mice. Exons 6–8 were excised by cre-mediated
recombination.
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recombinase activity using lacZ or X-gal reporters has been
shown in hypothalamic neurons (Wicksteed et al., 2010), we
showed that total hypothalamic Dmt1 expression was cre re-
combinase insensitive (Figure 5C); however, this finding
does not exclude that Dmt1 expression in hypothalamic subre-
gions is cre recombinase sensitive or that central-peripheral
pathways may impact b cell function in the Dmt1 knockout
mouse. DMT1 is highly expressed in both the exocrine and
endocrine pancreas in WT mice; tamoxifen treatment caused
complete and b cell-specific knockout of DMT-1 in islets
from the Cre+ mice without compensatory changes in other
iron transport-regulating genes (Figures 5D and S5A). Dmt1
KO did not induce ultrastructural changes in b cells (Fig-
ure S5B). Cytokine-induced apoptosis in islets from Dmt1 KO
mice was reduced by approximately 45% compared to WT
islets (Figure 5E, left), consistent with the levels of protection
obtained by iron chelation and siRNA knockdown of DMT-1
in vitro (Figure 4). Dmt1 knockout did not protect against
apoptosis induced by thapsigargin, a potent inducer of ROS-
and cytokine-independent islet cell apoptosis mediated via
inhibition of smooth endoplasmic reticulum calcium ATPase
2B (Tonnesen et al., 2009) (Figure 5E, right). LIP was signifi-
cantly reduced in IL-1b and IFN-g exposed Dmt1 knockout
islets (Figure 5F).
Dmt1 Knockout Improves Glucose-Stimulated Insulin
Secretion and Insulin Secretory Efficacy in
IL-1b-Exposed Islets
The stimulus-secretion coupling in insulin exocytosis involves
a glucose oxidation-dependent increase in the ATP/ADP ratio
but also ROS generation (Leloup et al., 2009). We therefore
anticipated that first-phase glucose-stimulated insulin secretion
(GSIS) would be lower in Dmt1 KO islets unchallenged by
inflammatory assault ex vivo. Indeed, this was the case (Figures
5G and 5H, top), highlighting a physiological role of iron and
ROS in the regulation of insulin exocytosis. Second-phase
GSIS was also significantly reduced, showing that glucose-
induced insulin synthesis is also iron dependent. In contrast,
when exposed to IL-1b, both first- and second-phase GSIS
from Dmt1 KO islets were significantly higher compared both
to cytokine-exposed cre– islets and control cre+ islets (Figures
5G and 5H, top). Insulin secretory efficacy expressed as a ratio
between the area under the curve of secreted insulin during the
first and second phase and the islet insulin content at the end(B) Immunohistochemical analysis of pancreata from TAM-treated mice was per
(C) DMT1 gene expression in isolated islets and hypothalamus from cre and cr
(D) Verification of DMT1 KO by immunohistochemistry of pancreatic sections 2 w
(E) Left: Cytokine induced apoptosis in isolated islets from TAM treated cre an
exposure to a mixture of 300 pg/ml IL-1b and 10 ng/ml IFN-g (Mix) (right), n = 4, +
apoptosis in isolated islets from TAM treated cre and cre+ animals measured
significant.
(F) Determination of the labile iron pool (LIP) in IL-1b- and IL-1b+IFN-g-exposed is
*p < 0.05.
(G) Insulin secretion from isolated cre and cre+ islets wasmeasured after perifus
supplemented with 3.0 mM glucose for 30 min, and then with 16.7 mM glucose
(H) Top: Area under the curve from perifusion experiment. Bottom: Total islet insu
the area under the curve over islet insulin content ratio. Graphs show means + S
See also Figure S5.
Cellof the perifusion was unaffected in cytokine-nonexposed Dmt1
KO islets ex vivo but markedly higher in these islets after expo-
sure to IL-1b (Figure 5H, bottom, and Figure S5C).
Dmt1 KO Improves Glucose Tolerance and Circulating
Insulin Levels in Multiple Low-Dose Streptozotocin and
High-Fat Diet-Induced Diabetes, Models of Type 1 and
Type 2 Diabetes, Respectively
To test the relevance of our model in type 1 and type 2 diabetes,
we characterized the metabolic phenotypes of (1) mice receiving
multiple low-doses of streptozotocin (MLDS) to provoke
immune-mediated b cell destruction and diabetes, (2) mice fed
a high-fat diet (HFD), and (3) unchallenged mice (Figures 6
and S6).
In the MLDS model of type 1 diabetes (Leiter, 1982), b cell
destruction in cre–mice was evidenced by a significant increase
in fasting blood glucose levels at day 19, 11 days after the last
injection of streptozotocin (Figures 6A and 6B) but MLDS had
no effect on weight and body composition (Figures 6C and
S6A). From day 19 to the end of the experiment on day 99, the
area under the fasting glucose curve was significantly reduced,
and glucose tolerance and circulating insulin levels were signifi-
cantly improved in MLDS treated Dmt1 KOmice (Figures 6B and
6D–6F).
HFD-induced diabetes in rodents leading to low-grade islet
inflammation and progressive b cell dysfunction and apoptosis
is a model of human type 2 diabetes (Eguchi et al., 2012;
Ehses et al., 2007). HFD significantly increased body weight
and fat body mass and reduced lean body mass in both
cre– and cre+ animals (Figures 6G and S6B). No effect of
b cell-specific Dmt1 KO on body composition was observed
(Figures 6G and S6B). In HFD Dmt1 KO mice, glucose
tolerance was significantly improved, correlating with signifi-
cantly enhanced insulin secretion in these animals (Figures
6H–6J).
The early effects of DMT1 deletion on b cell function were
investigated by glucose tolerance testing of unchallenged
mice. Three weeks after tamoxifen treatment, cre– and cre+
animals had normal glucose tolerance and insulin sensitivity sug-
gesting that the secretory defect demonstrated in unchallenged
b cell-specific Dmt1 KO ex vivo was compensated in vivo (Fig-
ure S6C). Intermediate and long-term Dmt1 deletion studied 5
and 21 weeks after tamoxifen treatment had no effects on
b cell function in the control groups from the MLDS and HFD
protocols, respectively (Figures 6D–6F and 6H–6J).formed to verify nuclear cre translocation 12 hr after the last TAM injection.
e+ mice by RT-PCR (n = 3–5, +SEM, *p < 0.05, Student’s t test).
eeks after completed TAM treatment.
d cre+ animals measured as cytosolic DNA-histone complexes after 16 hr of
SEM, ***p < 0.001 with two-way ANOVA. Right: Thapsigargin- (10 mM) induced
as cytosolic DNA-histone complexes after 24 hr, n = 4, means + SEM. ns, not
lets isolated from cre– and cre+mice. Means + SEM of n = 3–6, Student’s t test,
ion. Control or IL-1b-exposed islets were perifused with Krebs Ringer’s solution
for 50 min. Means + SEM of five independent experiments are shown.
lin was extracted after perifusion, and islet secretory efficacy was calculated as
EM, n = 5.
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Figure 6. b Cell-Specific DMT1 Knockout Lowers Blood Glucose and Improves Glucose Tolerance in Mice Treated with Multiple Low-Dose
Streptozotocin and High-Fat Diet
(A) Blood glucose in 4 hr fasted cre and cre+ mice treated with vehicle or streptozotocin (STZ) for the period indicated (Treatment). The graph shows means +
SEM, n = 16–18.
(B) Area under the curve of blood glucose from day 19 to 99. Means + SEM, n = 16–18, ***p < 0.001, Student’s t test.
(C) Weight development in STZ- and vehicle-treated DMT1 KO and WT mice. Means + SEM, n = 16–18.
(D) Oral glucose tolerance test (OGTT) in STZ-treated DMT1 KO and WT mice. Mice were fasted overnight and were given an oral gavage of 2.0 g/kg glucose at
0 min. Means + SEM, n = 16–18, *p < 0.05, ***p < 0.001, two-way ANOVA with repeated measures and Bonferroni’s post-hoc test.
(E) Area under the curve of OGTT. Means + SEM, n = 16–18, Student’s t test.
(F) Fasting and OGTT-induced insulin secretion. Samples were taken 60 min before and 15 min after oral gavage. Means + SEM, n = 16–18, *p < 0.05, Student’s
t test.
(G) Weight development in HFD and chow-fed DMT1 KO and WT mice. Means + SEM, n = 10–15, xp < 0.05 cre (HFD) versus cre (chow), *p < 0.05 **p < 0.01
cre+ (HFD) versus cre+ (chow).
(H) OGTT in DMT1 KO and WT mice after 21 weeks of high-fat feeding. Means + SEM, n = 10–15.
(I) Area under the curve of OGTT in HFD DMT1 KO and WT mice. Means + SEM, n = 10–15, *p < 0.05, Student’s t test.
(J) Fasting and OGTT-induced insulin secretion. Samples were taken 60 min before and 15 min after oral gavage. Means + SEM, n = 10–15, *p < 0.05, Student’s
t test.
See also Figure S6.
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Figure 7. Schematic Illustration of IL-1b-Induced Iron Uptake, ROS
Production, and Apoptosis in b Cells
In Pdx-1-expressing cells, binding of IL-1b to the receptor complex initiates
a cascade of NFkB-dependent DMT-1 expression, iron uptake, and conse-
quent iron-catalyzed ROS formation controlling b cell insulin secretion and
apoptosis. This chain of events can be modified by inhibition of NFkB
activation (IKKi), DMT knockdown (siRNA)/knockout (cre-lox), and iron
chelation.
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Our data suggest that aberrant cytokine-dependent upregula-
tion of cellular iron import via DMT1 primes b cells to ROS-medi-
ated inflammatory damage in a Pdx-1 dependent manner (Fig-
ure 7) by enhancing NFkB transcriptional activity, either by
central or peripheral pathways or both.
Pdx-1 has been suggested to recruit histone deacetylases
(HDAC) 1 and 2 to the insulin promoter (Mosley and Ozcan,
2004). We recently found that small-molecule HDAC inhibitors
reduce cytokine-induced NFkB transcriptional activity and
apoptosis in insulin-producing cells by inhibiting p65 DNA
binding (Christensen et al., 2011), and we confirmed this by
HDAC1 siRNA (Lundh et al., 2012). Accordingly, we hypothesize
that Pdx-1 may also recruit HDAC1 to the Dmt1 promoter,
thereby facilitating p65 binding and DMT1 gene transcription,
although a canonical Pdx-1 cis-binding element has yet to be
determined in the DMT1 promoter.
In vitro, b cell iron depletion with two different iron chelators
and DMT1 deletion by both siRNA and transgenic approaches
significantly decreased IL-1b-induced ROS production and
b cell apoptosis. In vivo, Dmt1 KO improved glucose tolerance
and circulating insulin levels in multiple low-dose streptozotocin
and high-fat diet-induced diabetes, models of islet inflammation
in type 1 and type 2 diabetes, respectively. These data provide
a molecular link explaining why iron chelator treatment improved
glucose tolerance and insulin secretion in the genetically obese
and diabetic ob/ob mouse (Cooksey et al., 2010) and why
feeding the OLETF rat model of obesity and diabetes an iron-
restricted diet increased plasma insulin levels and pancreatic
insulin content (Minamiyama et al., 2010).
The partial protection against IL-1b-induced b cell toxicity
conferred by iron chelation or Dmt1 knockdown was remarkably
consistent across our experimental models, emphasizing the
validity of the concept. Of note, Pdx-1-mediated sensitization
to IL-1b-induced apoptosis correlated also with enhanced
JNK, but not p38 or ERK MAPK activation, and inhibition of
JNK activity is known to reduce cytokine-mediated b cell
damage (Ammendrup et al., 2000; Bonny et al., 1998). Whether
JNK activation is secondary to DMT1-facilitated ROS formation,
or other priming pathways controlled by Pdx-1, remains to be
shown. However, when taken together, these observations
underscore that DMT1-dependent iron transport and ROS
formation is not an exhaustive explanation for Pdx-1-mediated
sensitization to inflammatory b cell damage, but that several
mechanisms yet to be demonstrated may operate in parallel.
Total hypothalamic DMT1 expression was cre recombinase
insensitive in our Dmt1 null mice. Notably, this finding does not
exclude that DMT-1 expression in hypothalamic subregions is
cre recombinase sensitive, and that central-peripheral pathways
may impact b cell function in the Dmt1 null mouse. Indeed,
inflammatory activation of the IKK/NFkB pathway in the liver
and hypothalamus are important in the pathogenesis of type 2
diabetes (Cai et al., 2005; Zhang et al., 2008; De Souza et al.,
2005; Milanski et al., 2012; Moraes et al., 2009).
Tissue targets of iron-driven cellular insults such as hepato-
cytes, cardiomyocytes, and pancreatic b cells typically have
high mitochondrial activity. Hence, cirrhosis and hepatomas,
heart failure, and diabetes are well-known complications toCelliron overload conditions (Aldouri et al., 1990; Eaton and Qian,
2002; Gabutti and Borgna-Pignatti, 1994; Niederau et al., 1985;
Rajpathak et al., 2009). It is likely that this association involves
a toxic effect of iron-catalyzed ROS on cellular organelles, in
particular highly active mitochondria and lysosomes (Eaton
and Qian, 2002). This is supported by findings of oxidative
stress-induced decreased insulin secretory capacity and b cell
apoptosis in mousemodels of primary hemochromatosis (Cook-
sey et al., 2004), and reduced insulin secretion in patients with
diabetes secondary to hemochromatosis (McClain et al.,
2006), in whom the insulin secretory defect can be ameliorated
by correcting iron overload by phlebotomy (Abraham et al.,
2006).
Our findings position DMT1 as an important interface between
iron and immunity, and there is both preclinical and clinical data
to support this notion. Intracellular iron accumulation mediates
IFN-g-, lipopolysacharide- (LPS), and TNF-a-induced oxidative
stress and cell death in endothelial cells, hepatocytes, and the
CNS (Autelli et al., 2005; Li and Frei, 2009; Nanami et al., 2005;
Warren et al., 1993; Zhang et al., 2005). DMT1 is strongly ex-
pressed in human monocytes and synovial fibroblasts from
patients with sterile inflammatory conditions such as rheumatoid
arthritis, and IL-1b mediates increased iron uptake in these cell
types (Telfer and Brock, 2002, 2004). Furthermore, the associa-
tion between the increased expression of proinflammatory cyto-
kines, pathological iron deposition, and oxidative stress in
neurodegenerative disorders like Alzheimer’s disease, Parkin-
son’s disease, and multiple sclerosis points to cytokines and
iron as central pathogenetic elements in the inflammatory
processes leading to these conditions (Berg and Youdim,
2006; Du et al., 2009; Salazar et al., 2008; Zhang et al., 2005).
Novel orally effective and well-tolerated iron chelators have
been developed and are now in routine clinical use for iron-over-
load related diseases (Cappellini and Piga, 2008). Iron chelation
protects immune cells against oxidative stress-induced DNAMetabolism 16, 449–461, October 3, 2012 ª2012 Elsevier Inc. 457
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et al., 2003), emphasizing the importance of endosomal/lyso-
somal redox-active iron in these processes. Iron chelation further
protects and improves the function of islet grafts in animal
models (Bradley et al., 1986; Nomikos et al., 1986; Vaithilingam
et al., 2010), in line with our demonstration of desferrioxamine
and deferasirox-mediated protection against cytokine-induced
b cell apoptosis. Hence, our findings have translational rele-
vance. Since large, prospective, epidemiological studies have
shown that elevated transferrin saturation in the general popula-
tion confers increased risk of developing any form of diabetes
(Ellervik et al., 2011), careful iron chelator titration in individuals
at risk of developing diabetes or even public health initiatives
to lower iron saturation without causing anemia could be envis-
aged as measures to prevent diabetes development.
In summary, aberrant cytokine-dependent upregulation of
cellular iron import via DMT-1 primes b cells to ROS-mediated
inflammatory damage. This concept may be generalizable to
other tissues that are targets of iron-overload damage and
may open avenues for the development of novel therapies for
chronic inflammatory diseases.
EXPERIMENTAL PROCEDURES
Details on reagents, cell lines, islet isolation, cell death, microarray, RT-PCR,
immunoblotting, transient transfection and Luciferase assay, and immunohis-
tochemistry are given in the Supplemental Experimental Procedures.
Islet Isolation
Pancreata were digested with collagenase, isolated by hand picking or
gradient centrifugation, and cultured as described in the Supplemental Exper-
imental Procedures.
Human Islets
Human islets were isolated from brain-dead donors with normal b cell function
as described (Lehmann et al., 2004) in compliance with institutional ethical
regulations and cultured as described (Maedler et al., 2004) with or without
160 pg/ml IL-1b plus 5 ng/ml IFN-g for 10 hr.
KO Mice and Animal Care
Transgenic mice and Wistar rats were bred at Taconic (Ry, Denmark). All
animals were maintained in a 12 hr light/dark cycle and fed ad libitum. The
floxed Slc11a2mouse was generated previously (Gunshin et al., 2005). Floxed
mice were crossed with a mouse carrying the Cre-ERT gene under control
of the Pdx-1 promoter from Dr. Melton’s laboratory provided by Dr. Serup,
the Hagedorn Research Institute, Gentofte, Denmark, and kept on a mixed
background (Gu et al., 2002). Cre and cre+ mice were administered four
consecutive intraperitoneal injections with tamoxifen (2.5 mg per mouse)
(Sigma-Aldrich, Denmark) diluted in ethanol-corn oil at 8–12 weeks of age.
Streptozotocin (Sigma-Aldrich) was dissolved in 0.1 M sodium-citrate
(Sigma-Aldrich) buffer with pH 4.5, and administered for five consecutive
days in a dose of 35 mg per kg body weight (BW). The b cell destruction was
followed by 4 hr fasting blood glucose measurements. High-fat diet supple-
mented with 500 mg iron per kg was purchased from Research Diets (New
Brunswick,NJ,product #D11101701).All animalworkwasperformed following
the guidelines and legislation of the Danish Animal Experiment Inspectorate.
Oral Glucose Tolerance Test and Plasma Insulin Measures
Mice were fasted over night (16 hr) and given an oral gavage of 2.0 g per kg BW
of glucose (Sigma-Aldrich) diluted in water. For blood glucose measurements,
tail vein blood was drawn, and blood glucose was measured with a hand-held
Bayer glucometer (Leverkusen, Germany). Plasma was collected from eye
blood for insulin determination in duplicates with a MesoScale Insulin Kit
(Gaithersburg, MD).458 Cell Metabolism 16, 449–461, October 3, 2012 ª2012 Elsevier InMeasurement of Cell Death
Apoptotic cell death was determined in duplicates of size-matched islets by
the detection of DNA-histone complexes present in the cytoplasmic fraction
of cells using Cell Death Detection ELISAPLUS (Roche, Basel, Switzerland)
(for details, see the Supplemental Experimental Procedures).
Transmission Electron Microscopy
Isolated islets cultured in 3.0 mMglucosemedium for 2 hr to establish baseline
insulin secretion and were then transferred to medium containing 16.7 mM
glucose for 15min prior to fixation in 2% glutaraldehyde in a 0.05M phosphate
buffer (pH 7.2). Sections were stained with uranyl acetate and lead citrate and
were subsequently examined with a Philips CM 100 TEM (Philips, Eindhoven,
The Netherlands) operated at an accelerating voltage of 80 kV. Digital images
were recorded with an OSIS Veleta digital slow scan 2k3 2k CCD camera and
the ITEM software package.
Nuclear Extract Electrophoretic Mobility Shift Assay
Cells were cultured in 10 cm dishes to 80%–85% confluence. Nuclear extracts
were isolated and electrophoretic mobility shift assay (EMSA) carried out as
described (Larsen et al., 2007). We controlled for loading by determining the
protein concentration in all nuclear extracts before addition of an identical
volume and excess amount (20 fmol) of radiolabelled oligonucleotide probe:
50-GTCAGCTTCAGAGGGACTTTCCGAGAGG-30. The protein concentrations
in the nuclear extracts were identical between the experimental conditions,
thereby allowing dilution with the same volume of buffer to obtain an identical
final protein concentration in all reaction mixtures (reaction volume 20 ml) and
the application of the same amount of protein (5 mg) per lane on the EMSA gels.
In supershift experiments, nuclear extracts were preincubated with anti-p65
antibody (sc-37; Santa Cruz) for 30 min at 4C.
Measurement of Intracellular Labile Iron Pool and Iron Supplement
The iron sensitive fluorescent dye calcein (Molecular Probes, Cambridge, UK)
was used to evaluate the effect of cytokines on the labile iron pool (LIP) in islets
(Epsztejn et al., 1997). In brief, islets were incubated in Krebs Ringer buffer with
10 mM glucose, 20 mM HEPES (GIBCO, Denmark) without bicarbonate
(pH 7.3) with 0.25 mM calcein probe for 1 hr. Excitation was measured at
488 nm and emission at 517 nm. After fluorescence detection, the total amount
of loaded calcein was detected after chelation of intracellular iron with
0.05 mM deferasirox for 15 min.
Measurement of Intracellular ROS/RNS Generation
ROS was measured by incorporation of 5-(and-6)-chloromethyl-20,70-dichlor-
odihydrofluorescein (H2DCFDA) (Molecular Probes, Invitrogen, Denmark).
Cells or islets were incubated in the dark with 10 mM H2DCFDA in PBS (for
cells) or Krebs Ringer buffer with 7 mM glucose (pH 7.4). Increase in fluores-
cence at 45 to 90 min was measured on a NovoStar Microplate Reader (Ram-
con, Denmark). Results are shown as delta fluorescence (t 90 min – t 45 min).
siRNA Transfection
Cells were cultured in antibiotic-freemedium for 24 hr before transfection over-
night with 30 nM siRNAs targeting DMT1 or with scrambled siRNA (QIAGEN).
Three different target siRNAs and one scrambled siRNA were used. For trans-
fection, siRNA and Dharmafect (Dharmacon, Chicago, IL) were diluted sepa-
rately in Optimem medium (Invitrogen) and incubated at room temperature
for 5 min. Lipid-siRNA complexes were allowed to form at room temperature
for 20 min in 1 ml Dharmafect:150 nM Optimem. After overnight transfection,
the medium was replaced by regular culture medium for cell recovery.
Islet Perifusion
The islet perifusion system was provided by Dr. Herbert Y. Gaisano, and has
been previously described (Kwan et al., 2007). Islets from cre+ or cre– litter-
mates were exposed 24 hr after isolation to cytokines. Fifty islets per condition
were preincubated in RPMIwith 3mMglucose prior to perifusion. Free-floating
islets were perifused, with a flow-rate of 1 ml per minute using Gilson Minipuls
3 peristaltic pump (Gilson, Middleton,WI), and insulin sampling was performed
over 1 min. Baseline insulin secretion was established after 30 min perifusion
with 3 mM glucose Krebs Ringer solution (pH 7.4, 0.1% BSA, 0.1 mMHEPES),
and glucose-stimulated insulin secretion was determined by perifusion ofc.
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sion, islets were collected, counted, and subjected to ethanol-HCl insulin
extraction and insulin measured by ELISA as described (Kekow et al., 1988).
Statistical Analysis
Data were analyzed with an unpaired t test assuming equal variances, or one-
and two-way ANOVA with either Dunett’s or Bonferroni’s post-hoc test.
Results are means + SEM. p values under 0.05 were considered significant,
indicated with *, while p values of p < 0.01 and p < 0.001 are marked with **
and ***, respectively.ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the microarray
data reported in this paper is GSE40642.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2012.09.001.
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